BUSINESS● LOW2h ago · Oct 29, 2026, 12:31 AM

ClearPoint Neuro outlines 5 IRRAflow milestones for 2027 as it prepares for potential AMT-130 approval timeline

Seeking Alpha Tech · global

ClearPoint Neuro has detailed five IRRAflow milestones for 2027 while preparing for the potential approval timeline of AMT-130. This outlines the company's product development strategy and future targets.

Read at Seeking Alpha Tech Ask the Analyst about this

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

See it on the live mapEvents around the world right now

More in Business

BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSEC BUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSEC BUSINESS26m agoDBV expects cash runway into Q3 2027 as it advances sequential FDA reviews for VIASKIN Peanut BLAsSeeking Alpha Tech BUSINESS27m agoRegulatory tightening in Hong Kong sees delistings outnumber resumptions: reportSouth China Morning Post